Total Revenue
Roivant Sciences Total Revenue increased by 26.1% to $2.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 66.7%, from $7.57M to $2.52M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows a downward trend with a -37.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.74M | $13.99M | $24.34M | $9.22M | $4.32M | $12.53M | $17.05M | $0.00 | $21.62M | $3.65M | $15.56M | $9.02M | $7.99M | $4.48M | $9.02M | $7.57M | $2.17M | $1.57M | $2.00M | $2.52M |
| QoQ Change | — | +80.8% | +74.0% | -62.1% | -53.2% | +190.2% | +36.1% | -100.0% | — | -83.1% | +326.6% | -42.0% | -11.4% | -44.0% | +101.5% | -16.1% | -71.3% | -27.6% | +27.2% | +26.1% |
| YoY Change | — | — | — | — | -44.2% | -10.4% | -29.9% | -100.0% | +400.7% | -70.9% | -8.7% | — | -63.1% | +22.7% | -42.1% | -16.1% | -72.8% | -64.9% | -77.8% | -66.7% |
Product Breakdown
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| License Milestone And Other Revenue | $7.56M | $7.81M | $13.72M | $4.97M | $18.68M | $16.47M | $9.62M | $36.77M |
| Product | $4.97M | $9.24M | $13.66M | $16.66M | — | — | — | — |
| Total | $12.53M | $17.05M | $0.00 | $21.62M | $3.65M | $15.56M | $9.02M | $7.99M |
License Milestone And Other Revenue was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| Reportable Segment | $1.57M | $2.00M | $2.52M |
| Total | $1.57M | $2.00M | $2.52M |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's total revenue?
- Roivant Sciences (ROIV) reported total revenue of $2.52M in Q1 2026.
- How has Roivant Sciences's total revenue changed year-over-year?
- Roivant Sciences's total revenue decreased by 66.7% year-over-year, from $7.57M to $2.52M.
- What is the long-term trend for Roivant Sciences's total revenue?
- Over 4 years (2021 to 2025), Roivant Sciences's total revenue has grown at a -37.8% compound annual growth rate (CAGR), from $55.29M to $8.26M.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.